Company / Working Capital
NEPHROS INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$8.5M
FY2025
5-year range
$6.3M / $11.2M
FY2021-FY2025
Trend
+25.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $6M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of -9.4%.
Improved from $6M to $8M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +7.3%
- 5-Year CAGR
- -9.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -9.4%, indicating a declining trend.
- In FY2025, working capital increased 25.5% year-over-year.
- Peak working capital was recorded in FY2020.
- Lowest working capital in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.5M | +25.5% |
| FY2024 | $6.7M | +7.1% |
| FY2023 | $6.3M | -8.1% |
| FY2022 | $6.8M | -39.1% |
| FY2021 | $11.2M | -18.7% |
| FY2020 | $13.8M | +135.5% |
| FY2019 | $5.9M | +6.4% |
| FY2018 | $5.5M | +184.8% |
| FY2017 | $1.9M | +425.2% |
| FY2016 | $369.0K | -75.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026